Global Implantable Left Ventricular Assist Device Market Growth 2026-2032
The global Implantable Left Ventricular Assist Device market size is predicted to grow from US$ 2185 million in 2025 to US$ 4520 million in 2032; it is expected to grow at a CAGR of 11.2% from 2026 to 2032.
Left Ventricular Assist Devices (LVADs) are mechanical circulatory support systems surgically implanted for permanent or long-term assistance or replacement of left ventricular pumping function. LVAD systems typically comprise a pump, inflow and outflow conduits, controller and power interfaces, and blood-contacting biocompatible surfaces; designs employ axial or centrifugal pumps with ongoing refinements in bearings (magnetic levitation or mechanical supports), coatings and sealing technologies to minimize thrombosis and hemolysis. Clinically, LVADs are applied as bridge-to-transplant, destination therapy, or bridge-to-recovery, offering durable circulatory support where donor organs are limited or patients are not transplant candidates—thereby improving survival and quality of life. Development priorities include device longevity, hemocompatibility, reduced size and noise, and integration of remote monitoring and simplified follow-up to increase clinician adoption and patient acceptance.In 2024, global Left Ventricular Assist Devices production reached approximately 40.28 units, with an average global market price of around US$ 50000 perunit.
The implantable LVAD market is at a pivotal stage of transition from early adoption to broader commercialization. Company annual reports and regulatory communications consistently highlight the growing burden of heart failure and the chronic shortage of donor organs—conditions that position durable mechanical circulatory support as a focus for both clinicians and policymakers. Technological advancements (including more robust magnetic levitation bearings, advanced antithrombotic coatings, and smaller pump footprints), maturing clinical pathways, and accumulated surgical expertise at specialty centers are lowering perceived complication risks and increasing hospital procurement intent. Moreover, regulators in multiple jurisdictions have clarified frameworks for LVAD indications, labeling expansions and post-market management, and reimbursement environments in several developed markets are showing supportive signals—creating an institutional and financial foundation for commercialization and network expansion.
Despite clear opportunities, material challenges persist. Device-related adverse events (pump thrombosis, stroke, infection, and device longevity concerns) remain central clinical and regulatory issues; any safety event can quickly erode clinical and patient trust and slow adoption. The total cost of ownership is high—encompassing device, surgical implantation, and postoperative management—which puts pressure on reimbursement and hospital purchasing decisions. Supply stability and price volatility for critical upstream components and materials (e.g., rare earth magnets for magnetic suspension, precision ceramics, medical-grade polymers) can affect production pacing and margins. Variability in regulatory pathways across countries and strict post-market surveillance (including recalls and safety updates) are systemic risks that manufacturers must continually manage.
Downstream stakeholders—hospitals, cardiac surgical teams, and patients—are shifting their focus from mere survival to meaningful improvements in post-implant quality of life and service experience. Compact, low-noise, low-complication devices with straightforward maintenance are increasingly preferred; remote monitoring, data-driven alerts, and comprehensive follow-up programs are key selection criteria for clinical sites. As clinical evidence accumulates and indications expand (for example via updated labeling or anticoagulation management guidance), clinician confidence in LVAD therapy is rising and destination therapy acceptance among non-transplant candidates is increasing. Hospitals are also emphasizing whether suppliers can deliver an integrated service bundle—from device delivery to operator training, complication management, and long-term follow-up.
The upstream material ecosystem for LVADs is highly specialized and technically demanding, directly affecting device performance and safety. Pump housings and structural components require high-strength, corrosion-resistant alloys and precision metalworking; bearings and support systems often utilize precision ceramics or high-hardness carbon-based coatings to minimize wear; blood-contacting interfaces rely on medical-grade biopolymers combined with antithrombotic and antibacterial surface treatments to reduce complication risk. High-performance permanent magnets, electrical insulation and conductive materials for motor and suspension systems are significant cost and supply risk factors. Material availability, processing sophistication (for example coating uniformity and surface roughness control), and upstream suppliers’ quality systems and regulatory certifications (meeting FDA/CE/NMPA standards) are fundamental determinants of whether devices can be scaled, sustainably supplied, and meet clinical safety expectations.The average gross profit margin of this product is 83.5%.
LP Information, Inc. (LPI) ' newest research report, the “Implantable Left Ventricular Assist Device Industry Forecast” looks at past sales and reviews total world Implantable Left Ventricular Assist Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Implantable Left Ventricular Assist Device sales for 2026 through 2032. With Implantable Left Ventricular Assist Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implantable Left Ventricular Assist Device industry.
This Insight Report provides a comprehensive analysis of the global Implantable Left Ventricular Assist Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implantable Left Ventricular Assist Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implantable Left Ventricular Assist Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implantable Left Ventricular Assist Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implantable Left Ventricular Assist Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Left Ventricular Assist Device market by product type, application, key manufacturers and key regions and countries.
Left Ventricular Assist Devices (LVADs) are mechanical circulatory support systems surgically implanted for permanent or long-term assistance or replacement of left ventricular pumping function. LVAD systems typically comprise a pump, inflow and outflow conduits, controller and power interfaces, and blood-contacting biocompatible surfaces; designs employ axial or centrifugal pumps with ongoing refinements in bearings (magnetic levitation or mechanical supports), coatings and sealing technologies to minimize thrombosis and hemolysis. Clinically, LVADs are applied as bridge-to-transplant, destination therapy, or bridge-to-recovery, offering durable circulatory support where donor organs are limited or patients are not transplant candidates—thereby improving survival and quality of life. Development priorities include device longevity, hemocompatibility, reduced size and noise, and integration of remote monitoring and simplified follow-up to increase clinician adoption and patient acceptance.In 2024, global Left Ventricular Assist Devices production reached approximately 40.28 units, with an average global market price of around US$ 50000 perunit.
The implantable LVAD market is at a pivotal stage of transition from early adoption to broader commercialization. Company annual reports and regulatory communications consistently highlight the growing burden of heart failure and the chronic shortage of donor organs—conditions that position durable mechanical circulatory support as a focus for both clinicians and policymakers. Technological advancements (including more robust magnetic levitation bearings, advanced antithrombotic coatings, and smaller pump footprints), maturing clinical pathways, and accumulated surgical expertise at specialty centers are lowering perceived complication risks and increasing hospital procurement intent. Moreover, regulators in multiple jurisdictions have clarified frameworks for LVAD indications, labeling expansions and post-market management, and reimbursement environments in several developed markets are showing supportive signals—creating an institutional and financial foundation for commercialization and network expansion.
Despite clear opportunities, material challenges persist. Device-related adverse events (pump thrombosis, stroke, infection, and device longevity concerns) remain central clinical and regulatory issues; any safety event can quickly erode clinical and patient trust and slow adoption. The total cost of ownership is high—encompassing device, surgical implantation, and postoperative management—which puts pressure on reimbursement and hospital purchasing decisions. Supply stability and price volatility for critical upstream components and materials (e.g., rare earth magnets for magnetic suspension, precision ceramics, medical-grade polymers) can affect production pacing and margins. Variability in regulatory pathways across countries and strict post-market surveillance (including recalls and safety updates) are systemic risks that manufacturers must continually manage.
Downstream stakeholders—hospitals, cardiac surgical teams, and patients—are shifting their focus from mere survival to meaningful improvements in post-implant quality of life and service experience. Compact, low-noise, low-complication devices with straightforward maintenance are increasingly preferred; remote monitoring, data-driven alerts, and comprehensive follow-up programs are key selection criteria for clinical sites. As clinical evidence accumulates and indications expand (for example via updated labeling or anticoagulation management guidance), clinician confidence in LVAD therapy is rising and destination therapy acceptance among non-transplant candidates is increasing. Hospitals are also emphasizing whether suppliers can deliver an integrated service bundle—from device delivery to operator training, complication management, and long-term follow-up.
The upstream material ecosystem for LVADs is highly specialized and technically demanding, directly affecting device performance and safety. Pump housings and structural components require high-strength, corrosion-resistant alloys and precision metalworking; bearings and support systems often utilize precision ceramics or high-hardness carbon-based coatings to minimize wear; blood-contacting interfaces rely on medical-grade biopolymers combined with antithrombotic and antibacterial surface treatments to reduce complication risk. High-performance permanent magnets, electrical insulation and conductive materials for motor and suspension systems are significant cost and supply risk factors. Material availability, processing sophistication (for example coating uniformity and surface roughness control), and upstream suppliers’ quality systems and regulatory certifications (meeting FDA/CE/NMPA standards) are fundamental determinants of whether devices can be scaled, sustainably supplied, and meet clinical safety expectations.The average gross profit margin of this product is 83.5%.
LP Information, Inc. (LPI) ' newest research report, the “Implantable Left Ventricular Assist Device Industry Forecast” looks at past sales and reviews total world Implantable Left Ventricular Assist Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Implantable Left Ventricular Assist Device sales for 2026 through 2032. With Implantable Left Ventricular Assist Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implantable Left Ventricular Assist Device industry.
This Insight Report provides a comprehensive analysis of the global Implantable Left Ventricular Assist Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implantable Left Ventricular Assist Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implantable Left Ventricular Assist Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implantable Left Ventricular Assist Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implantable Left Ventricular Assist Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Left Ventricular Assist Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- MagLev, Full-flow Suspension
- Hybrid Bearing
- Other
Segmentation by Application:
- Hospital
- Specialized Hospital
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- J & J (AbioMed)
- Abbott (Thoratec)
- Medtronic (HeartWare)
- Berlin Heart
- Jarvik Heart
- Sun Medical Technology Research
- ReliantHeart
- EVAHEART
- BRIOHEALTH
- Rocor Medical
- Corheart
- magAssist-Technology
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Implantable Left Ventricular Assist Device market?
- What factors are driving Implantable Left Ventricular Assist Device market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Implantable Left Ventricular Assist Device market opportunities vary by end market size?
- How does Implantable Left Ventricular Assist Device break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Implantable Left Ventricular Assist Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Implantable Left Ventricular Assist Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Implantable Left Ventricular Assist Device by Country/Region, 2021, 2025 & 2032
2.2 Implantable Left Ventricular Assist Device Segment by Type
2.2.1 MagLev, Full-flow Suspension
2.2.2 Hybrid Bearing
2.2.3 Other
2.2.4 Implantable Left Ventricular Assist Device Sales by Type
2.2.4.1 Global Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
2.2.4.2 Global Implantable Left Ventricular Assist Device Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Implantable Left Ventricular Assist Device Sale Price by Type (2021-2026)
2.3 Implantable Left Ventricular Assist Device Segment by Application
2.3.1 Hospital
2.3.2 Specialized Hospital
2.3.3 Other
2.3.4 Implantable Left Ventricular Assist Device Sales by Application
2.3.4.1 Global Implantable Left Ventricular Assist Device Sale Market Share by Application (2021-2026)
2.3.4.2 Global Implantable Left Ventricular Assist Device Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Implantable Left Ventricular Assist Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Implantable Left Ventricular Assist Device Breakdown Data by Company
3.1.1 Global Implantable Left Ventricular Assist Device Annual Sales by Company (2021-2026)
3.1.2 Global Implantable Left Ventricular Assist Device Sales Market Share by Company (2021-2026)
3.2 Global Implantable Left Ventricular Assist Device Annual Revenue by Company (2021-2026)
3.2.1 Global Implantable Left Ventricular Assist Device Revenue by Company (2021-2026)
3.2.2 Global Implantable Left Ventricular Assist Device Revenue Market Share by Company (2021-2026)
3.3 Global Implantable Left Ventricular Assist Device Sale Price by Company
3.4 Key Manufacturers Implantable Left Ventricular Assist Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Implantable Left Ventricular Assist Device Product Location Distribution
3.4.2 Players Implantable Left Ventricular Assist Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMPLANTABLE LEFT VENTRICULAR ASSIST DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Implantable Left Ventricular Assist Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Implantable Left Ventricular Assist Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Implantable Left Ventricular Assist Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Implantable Left Ventricular Assist Device Market Size by Country/Region (2021-2026)
4.2.1 Global Implantable Left Ventricular Assist Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Implantable Left Ventricular Assist Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Implantable Left Ventricular Assist Device Sales Growth
4.4 APAC Implantable Left Ventricular Assist Device Sales Growth
4.5 Europe Implantable Left Ventricular Assist Device Sales Growth
4.6 Middle East & Africa Implantable Left Ventricular Assist Device Sales Growth
5 AMERICAS
5.1 Americas Implantable Left Ventricular Assist Device Sales by Country
5.1.1 Americas Implantable Left Ventricular Assist Device Sales by Country (2021-2026)
5.1.2 Americas Implantable Left Ventricular Assist Device Revenue by Country (2021-2026)
5.2 Americas Implantable Left Ventricular Assist Device Sales by Type (2021-2026)
5.3 Americas Implantable Left Ventricular Assist Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Implantable Left Ventricular Assist Device Sales by Region
6.1.1 APAC Implantable Left Ventricular Assist Device Sales by Region (2021-2026)
6.1.2 APAC Implantable Left Ventricular Assist Device Revenue by Region (2021-2026)
6.2 APAC Implantable Left Ventricular Assist Device Sales by Type (2021-2026)
6.3 APAC Implantable Left Ventricular Assist Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Implantable Left Ventricular Assist Device by Country
7.1.1 Europe Implantable Left Ventricular Assist Device Sales by Country (2021-2026)
7.1.2 Europe Implantable Left Ventricular Assist Device Revenue by Country (2021-2026)
7.2 Europe Implantable Left Ventricular Assist Device Sales by Type (2021-2026)
7.3 Europe Implantable Left Ventricular Assist Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Implantable Left Ventricular Assist Device by Country
8.1.1 Middle East & Africa Implantable Left Ventricular Assist Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Implantable Left Ventricular Assist Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Implantable Left Ventricular Assist Device Sales by Type (2021-2026)
8.3 Middle East & Africa Implantable Left Ventricular Assist Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Implantable Left Ventricular Assist Device
10.3 Manufacturing Process Analysis of Implantable Left Ventricular Assist Device
10.4 Industry Chain Structure of Implantable Left Ventricular Assist Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Implantable Left Ventricular Assist Device Distributors
11.3 Implantable Left Ventricular Assist Device Customer
12 WORLD FORECAST REVIEW FOR IMPLANTABLE LEFT VENTRICULAR ASSIST DEVICE BY GEOGRAPHIC REGION
12.1 Global Implantable Left Ventricular Assist Device Market Size Forecast by Region
12.1.1 Global Implantable Left Ventricular Assist Device Forecast by Region (2027-2032)
12.1.2 Global Implantable Left Ventricular Assist Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Implantable Left Ventricular Assist Device Forecast by Type (2027-2032)
12.7 Global Implantable Left Ventricular Assist Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 J & J (AbioMed)
13.1.1 J & J (AbioMed) Company Information
13.1.2 J & J (AbioMed) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.1.3 J & J (AbioMed) Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 J & J (AbioMed) Main Business Overview
13.1.5 J & J (AbioMed) Latest Developments
13.2 Abbott (Thoratec)
13.2.1 Abbott (Thoratec) Company Information
13.2.2 Abbott (Thoratec) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.2.3 Abbott (Thoratec) Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Abbott (Thoratec) Main Business Overview
13.2.5 Abbott (Thoratec) Latest Developments
13.3 Medtronic (HeartWare)
13.3.1 Medtronic (HeartWare) Company Information
13.3.2 Medtronic (HeartWare) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.3.3 Medtronic (HeartWare) Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic (HeartWare) Main Business Overview
13.3.5 Medtronic (HeartWare) Latest Developments
13.4 Berlin Heart
13.4.1 Berlin Heart Company Information
13.4.2 Berlin Heart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.4.3 Berlin Heart Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Berlin Heart Main Business Overview
13.4.5 Berlin Heart Latest Developments
13.5 Jarvik Heart
13.5.1 Jarvik Heart Company Information
13.5.2 Jarvik Heart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.5.3 Jarvik Heart Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Jarvik Heart Main Business Overview
13.5.5 Jarvik Heart Latest Developments
13.6 Sun Medical Technology Research
13.6.1 Sun Medical Technology Research Company Information
13.6.2 Sun Medical Technology Research Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.6.3 Sun Medical Technology Research Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Medical Technology Research Main Business Overview
13.6.5 Sun Medical Technology Research Latest Developments
13.7 ReliantHeart
13.7.1 ReliantHeart Company Information
13.7.2 ReliantHeart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.7.3 ReliantHeart Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ReliantHeart Main Business Overview
13.7.5 ReliantHeart Latest Developments
13.8 EVAHEART
13.8.1 EVAHEART Company Information
13.8.2 EVAHEART Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.8.3 EVAHEART Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 EVAHEART Main Business Overview
13.8.5 EVAHEART Latest Developments
13.9 BRIOHEALTH
13.9.1 BRIOHEALTH Company Information
13.9.2 BRIOHEALTH Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.9.3 BRIOHEALTH Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BRIOHEALTH Main Business Overview
13.9.5 BRIOHEALTH Latest Developments
13.10 Rocor Medical
13.10.1 Rocor Medical Company Information
13.10.2 Rocor Medical Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.10.3 Rocor Medical Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Rocor Medical Main Business Overview
13.10.5 Rocor Medical Latest Developments
13.11 Corheart
13.11.1 Corheart Company Information
13.11.2 Corheart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.11.3 Corheart Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Corheart Main Business Overview
13.11.5 Corheart Latest Developments
13.12 magAssist-Technology
13.12.1 magAssist-Technology Company Information
13.12.2 magAssist-Technology Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.12.3 magAssist-Technology Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 magAssist-Technology Main Business Overview
13.12.5 magAssist-Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Implantable Left Ventricular Assist Device Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Implantable Left Ventricular Assist Device by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Implantable Left Ventricular Assist Device by Country/Region, 2021, 2025 & 2032
2.2 Implantable Left Ventricular Assist Device Segment by Type
2.2.1 MagLev, Full-flow Suspension
2.2.2 Hybrid Bearing
2.2.3 Other
2.2.4 Implantable Left Ventricular Assist Device Sales by Type
2.2.4.1 Global Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
2.2.4.2 Global Implantable Left Ventricular Assist Device Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Implantable Left Ventricular Assist Device Sale Price by Type (2021-2026)
2.3 Implantable Left Ventricular Assist Device Segment by Application
2.3.1 Hospital
2.3.2 Specialized Hospital
2.3.3 Other
2.3.4 Implantable Left Ventricular Assist Device Sales by Application
2.3.4.1 Global Implantable Left Ventricular Assist Device Sale Market Share by Application (2021-2026)
2.3.4.2 Global Implantable Left Ventricular Assist Device Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Implantable Left Ventricular Assist Device Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Implantable Left Ventricular Assist Device Breakdown Data by Company
3.1.1 Global Implantable Left Ventricular Assist Device Annual Sales by Company (2021-2026)
3.1.2 Global Implantable Left Ventricular Assist Device Sales Market Share by Company (2021-2026)
3.2 Global Implantable Left Ventricular Assist Device Annual Revenue by Company (2021-2026)
3.2.1 Global Implantable Left Ventricular Assist Device Revenue by Company (2021-2026)
3.2.2 Global Implantable Left Ventricular Assist Device Revenue Market Share by Company (2021-2026)
3.3 Global Implantable Left Ventricular Assist Device Sale Price by Company
3.4 Key Manufacturers Implantable Left Ventricular Assist Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Implantable Left Ventricular Assist Device Product Location Distribution
3.4.2 Players Implantable Left Ventricular Assist Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMPLANTABLE LEFT VENTRICULAR ASSIST DEVICE BY GEOGRAPHIC REGION
4.1 World Historic Implantable Left Ventricular Assist Device Market Size by Geographic Region (2021-2026)
4.1.1 Global Implantable Left Ventricular Assist Device Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Implantable Left Ventricular Assist Device Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Implantable Left Ventricular Assist Device Market Size by Country/Region (2021-2026)
4.2.1 Global Implantable Left Ventricular Assist Device Annual Sales by Country/Region (2021-2026)
4.2.2 Global Implantable Left Ventricular Assist Device Annual Revenue by Country/Region (2021-2026)
4.3 Americas Implantable Left Ventricular Assist Device Sales Growth
4.4 APAC Implantable Left Ventricular Assist Device Sales Growth
4.5 Europe Implantable Left Ventricular Assist Device Sales Growth
4.6 Middle East & Africa Implantable Left Ventricular Assist Device Sales Growth
5 AMERICAS
5.1 Americas Implantable Left Ventricular Assist Device Sales by Country
5.1.1 Americas Implantable Left Ventricular Assist Device Sales by Country (2021-2026)
5.1.2 Americas Implantable Left Ventricular Assist Device Revenue by Country (2021-2026)
5.2 Americas Implantable Left Ventricular Assist Device Sales by Type (2021-2026)
5.3 Americas Implantable Left Ventricular Assist Device Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Implantable Left Ventricular Assist Device Sales by Region
6.1.1 APAC Implantable Left Ventricular Assist Device Sales by Region (2021-2026)
6.1.2 APAC Implantable Left Ventricular Assist Device Revenue by Region (2021-2026)
6.2 APAC Implantable Left Ventricular Assist Device Sales by Type (2021-2026)
6.3 APAC Implantable Left Ventricular Assist Device Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Implantable Left Ventricular Assist Device by Country
7.1.1 Europe Implantable Left Ventricular Assist Device Sales by Country (2021-2026)
7.1.2 Europe Implantable Left Ventricular Assist Device Revenue by Country (2021-2026)
7.2 Europe Implantable Left Ventricular Assist Device Sales by Type (2021-2026)
7.3 Europe Implantable Left Ventricular Assist Device Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Implantable Left Ventricular Assist Device by Country
8.1.1 Middle East & Africa Implantable Left Ventricular Assist Device Sales by Country (2021-2026)
8.1.2 Middle East & Africa Implantable Left Ventricular Assist Device Revenue by Country (2021-2026)
8.2 Middle East & Africa Implantable Left Ventricular Assist Device Sales by Type (2021-2026)
8.3 Middle East & Africa Implantable Left Ventricular Assist Device Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Implantable Left Ventricular Assist Device
10.3 Manufacturing Process Analysis of Implantable Left Ventricular Assist Device
10.4 Industry Chain Structure of Implantable Left Ventricular Assist Device
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Implantable Left Ventricular Assist Device Distributors
11.3 Implantable Left Ventricular Assist Device Customer
12 WORLD FORECAST REVIEW FOR IMPLANTABLE LEFT VENTRICULAR ASSIST DEVICE BY GEOGRAPHIC REGION
12.1 Global Implantable Left Ventricular Assist Device Market Size Forecast by Region
12.1.1 Global Implantable Left Ventricular Assist Device Forecast by Region (2027-2032)
12.1.2 Global Implantable Left Ventricular Assist Device Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Implantable Left Ventricular Assist Device Forecast by Type (2027-2032)
12.7 Global Implantable Left Ventricular Assist Device Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 J & J (AbioMed)
13.1.1 J & J (AbioMed) Company Information
13.1.2 J & J (AbioMed) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.1.3 J & J (AbioMed) Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 J & J (AbioMed) Main Business Overview
13.1.5 J & J (AbioMed) Latest Developments
13.2 Abbott (Thoratec)
13.2.1 Abbott (Thoratec) Company Information
13.2.2 Abbott (Thoratec) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.2.3 Abbott (Thoratec) Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Abbott (Thoratec) Main Business Overview
13.2.5 Abbott (Thoratec) Latest Developments
13.3 Medtronic (HeartWare)
13.3.1 Medtronic (HeartWare) Company Information
13.3.2 Medtronic (HeartWare) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.3.3 Medtronic (HeartWare) Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Medtronic (HeartWare) Main Business Overview
13.3.5 Medtronic (HeartWare) Latest Developments
13.4 Berlin Heart
13.4.1 Berlin Heart Company Information
13.4.2 Berlin Heart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.4.3 Berlin Heart Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Berlin Heart Main Business Overview
13.4.5 Berlin Heart Latest Developments
13.5 Jarvik Heart
13.5.1 Jarvik Heart Company Information
13.5.2 Jarvik Heart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.5.3 Jarvik Heart Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Jarvik Heart Main Business Overview
13.5.5 Jarvik Heart Latest Developments
13.6 Sun Medical Technology Research
13.6.1 Sun Medical Technology Research Company Information
13.6.2 Sun Medical Technology Research Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.6.3 Sun Medical Technology Research Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sun Medical Technology Research Main Business Overview
13.6.5 Sun Medical Technology Research Latest Developments
13.7 ReliantHeart
13.7.1 ReliantHeart Company Information
13.7.2 ReliantHeart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.7.3 ReliantHeart Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ReliantHeart Main Business Overview
13.7.5 ReliantHeart Latest Developments
13.8 EVAHEART
13.8.1 EVAHEART Company Information
13.8.2 EVAHEART Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.8.3 EVAHEART Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 EVAHEART Main Business Overview
13.8.5 EVAHEART Latest Developments
13.9 BRIOHEALTH
13.9.1 BRIOHEALTH Company Information
13.9.2 BRIOHEALTH Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.9.3 BRIOHEALTH Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BRIOHEALTH Main Business Overview
13.9.5 BRIOHEALTH Latest Developments
13.10 Rocor Medical
13.10.1 Rocor Medical Company Information
13.10.2 Rocor Medical Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.10.3 Rocor Medical Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Rocor Medical Main Business Overview
13.10.5 Rocor Medical Latest Developments
13.11 Corheart
13.11.1 Corheart Company Information
13.11.2 Corheart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.11.3 Corheart Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Corheart Main Business Overview
13.11.5 Corheart Latest Developments
13.12 magAssist-Technology
13.12.1 magAssist-Technology Company Information
13.12.2 magAssist-Technology Implantable Left Ventricular Assist Device Product Portfolios and Specifications
13.12.3 magAssist-Technology Implantable Left Ventricular Assist Device Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 magAssist-Technology Main Business Overview
13.12.5 magAssist-Technology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Implantable Left Ventricular Assist Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Implantable Left Ventricular Assist Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of MagLev, Full-flow Suspension
Table 4. Major Players of Hybrid Bearing
Table 5. Major Players of Other
Table 6. Global Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 7. Global Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Table 8. Global Implantable Left Ventricular Assist Device Revenue by Type (2021-2026) & ($ million)
Table 9. Global Implantable Left Ventricular Assist Device Revenue Market Share by Type (2021-2026)
Table 10. Global Implantable Left Ventricular Assist Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Implantable Left Ventricular Assist Device Sale by Application (2021-2026) & (K Units)
Table 12. Global Implantable Left Ventricular Assist Device Sale Market Share by Application (2021-2026)
Table 13. Global Implantable Left Ventricular Assist Device Revenue by Application (2021-2026) & ($ million)
Table 14. Global Implantable Left Ventricular Assist Device Revenue Market Share by Application (2021-2026)
Table 15. Global Implantable Left Ventricular Assist Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Implantable Left Ventricular Assist Device Sales by Company (2021-2026) & (K Units)
Table 17. Global Implantable Left Ventricular Assist Device Sales Market Share by Company (2021-2026)
Table 18. Global Implantable Left Ventricular Assist Device Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Implantable Left Ventricular Assist Device Revenue Market Share by Company (2021-2026)
Table 20. Global Implantable Left Ventricular Assist Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Implantable Left Ventricular Assist Device Producing Area Distribution and Sales Area
Table 22. Players Implantable Left Ventricular Assist Device Products Offered
Table 23. Implantable Left Ventricular Assist Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Implantable Left Ventricular Assist Device Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Implantable Left Ventricular Assist Device Sales Market Share Geographic Region (2021-2026)
Table 28. Global Implantable Left Ventricular Assist Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Implantable Left Ventricular Assist Device Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Implantable Left Ventricular Assist Device Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Implantable Left Ventricular Assist Device Sales Market Share by Country/Region (2021-2026)
Table 32. Global Implantable Left Ventricular Assist Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Implantable Left Ventricular Assist Device Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Implantable Left Ventricular Assist Device Sales by Country (2021-2026) & (K Units)
Table 35. Americas Implantable Left Ventricular Assist Device Sales Market Share by Country (2021-2026)
Table 36. Americas Implantable Left Ventricular Assist Device Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 38. Americas Implantable Left Ventricular Assist Device Sales by Application (2021-2026) & (K Units)
Table 39. APAC Implantable Left Ventricular Assist Device Sales by Region (2021-2026) & (K Units)
Table 40. APAC Implantable Left Ventricular Assist Device Sales Market Share by Region (2021-2026)
Table 41. APAC Implantable Left Ventricular Assist Device Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 43. APAC Implantable Left Ventricular Assist Device Sales by Application (2021-2026) & (K Units)
Table 44. Europe Implantable Left Ventricular Assist Device Sales by Country (2021-2026) & (K Units)
Table 45. Europe Implantable Left Ventricular Assist Device Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 47. Europe Implantable Left Ventricular Assist Device Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Implantable Left Ventricular Assist Device Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Implantable Left Ventricular Assist Device Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Implantable Left Ventricular Assist Device Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Implantable Left Ventricular Assist Device
Table 53. Key Market Challenges & Risks of Implantable Left Ventricular Assist Device
Table 54. Key Industry Trends of Implantable Left Ventricular Assist Device
Table 55. Implantable Left Ventricular Assist Device Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Implantable Left Ventricular Assist Device Distributors List
Table 58. Implantable Left Ventricular Assist Device Customer List
Table 59. Global Implantable Left Ventricular Assist Device Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Implantable Left Ventricular Assist Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Implantable Left Ventricular Assist Device Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Implantable Left Ventricular Assist Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Implantable Left Ventricular Assist Device Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Implantable Left Ventricular Assist Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Implantable Left Ventricular Assist Device Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Implantable Left Ventricular Assist Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Implantable Left Ventricular Assist Device Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Implantable Left Ventricular Assist Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Implantable Left Ventricular Assist Device Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Implantable Left Ventricular Assist Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Implantable Left Ventricular Assist Device Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Implantable Left Ventricular Assist Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. J & J (AbioMed) Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 74. J & J (AbioMed) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 75. J & J (AbioMed) Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. J & J (AbioMed) Main Business
Table 77. J & J (AbioMed) Latest Developments
Table 78. Abbott (Thoratec) Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott (Thoratec) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 80. Abbott (Thoratec) Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Abbott (Thoratec) Main Business
Table 82. Abbott (Thoratec) Latest Developments
Table 83. Medtronic (HeartWare) Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 84. Medtronic (HeartWare) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 85. Medtronic (HeartWare) Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Medtronic (HeartWare) Main Business
Table 87. Medtronic (HeartWare) Latest Developments
Table 88. Berlin Heart Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 89. Berlin Heart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 90. Berlin Heart Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Berlin Heart Main Business
Table 92. Berlin Heart Latest Developments
Table 93. Jarvik Heart Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Jarvik Heart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 95. Jarvik Heart Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Jarvik Heart Main Business
Table 97. Jarvik Heart Latest Developments
Table 98. Sun Medical Technology Research Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Sun Medical Technology Research Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 100. Sun Medical Technology Research Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Sun Medical Technology Research Main Business
Table 102. Sun Medical Technology Research Latest Developments
Table 103. ReliantHeart Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 104. ReliantHeart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 105. ReliantHeart Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. ReliantHeart Main Business
Table 107. ReliantHeart Latest Developments
Table 108. EVAHEART Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 109. EVAHEART Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 110. EVAHEART Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. EVAHEART Main Business
Table 112. EVAHEART Latest Developments
Table 113. BRIOHEALTH Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 114. BRIOHEALTH Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 115. BRIOHEALTH Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. BRIOHEALTH Main Business
Table 117. BRIOHEALTH Latest Developments
Table 118. Rocor Medical Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Rocor Medical Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 120. Rocor Medical Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Rocor Medical Main Business
Table 122. Rocor Medical Latest Developments
Table 123. Corheart Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Corheart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 125. Corheart Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Corheart Main Business
Table 127. Corheart Latest Developments
Table 128. magAssist-Technology Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 129. magAssist-Technology Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 130. magAssist-Technology Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. magAssist-Technology Main Business
Table 132. magAssist-Technology Latest Developments
Table 1. Implantable Left Ventricular Assist Device Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Implantable Left Ventricular Assist Device Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of MagLev, Full-flow Suspension
Table 4. Major Players of Hybrid Bearing
Table 5. Major Players of Other
Table 6. Global Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 7. Global Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Table 8. Global Implantable Left Ventricular Assist Device Revenue by Type (2021-2026) & ($ million)
Table 9. Global Implantable Left Ventricular Assist Device Revenue Market Share by Type (2021-2026)
Table 10. Global Implantable Left Ventricular Assist Device Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Implantable Left Ventricular Assist Device Sale by Application (2021-2026) & (K Units)
Table 12. Global Implantable Left Ventricular Assist Device Sale Market Share by Application (2021-2026)
Table 13. Global Implantable Left Ventricular Assist Device Revenue by Application (2021-2026) & ($ million)
Table 14. Global Implantable Left Ventricular Assist Device Revenue Market Share by Application (2021-2026)
Table 15. Global Implantable Left Ventricular Assist Device Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Implantable Left Ventricular Assist Device Sales by Company (2021-2026) & (K Units)
Table 17. Global Implantable Left Ventricular Assist Device Sales Market Share by Company (2021-2026)
Table 18. Global Implantable Left Ventricular Assist Device Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Implantable Left Ventricular Assist Device Revenue Market Share by Company (2021-2026)
Table 20. Global Implantable Left Ventricular Assist Device Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Implantable Left Ventricular Assist Device Producing Area Distribution and Sales Area
Table 22. Players Implantable Left Ventricular Assist Device Products Offered
Table 23. Implantable Left Ventricular Assist Device Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Implantable Left Ventricular Assist Device Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Implantable Left Ventricular Assist Device Sales Market Share Geographic Region (2021-2026)
Table 28. Global Implantable Left Ventricular Assist Device Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Implantable Left Ventricular Assist Device Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Implantable Left Ventricular Assist Device Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Implantable Left Ventricular Assist Device Sales Market Share by Country/Region (2021-2026)
Table 32. Global Implantable Left Ventricular Assist Device Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Implantable Left Ventricular Assist Device Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Implantable Left Ventricular Assist Device Sales by Country (2021-2026) & (K Units)
Table 35. Americas Implantable Left Ventricular Assist Device Sales Market Share by Country (2021-2026)
Table 36. Americas Implantable Left Ventricular Assist Device Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 38. Americas Implantable Left Ventricular Assist Device Sales by Application (2021-2026) & (K Units)
Table 39. APAC Implantable Left Ventricular Assist Device Sales by Region (2021-2026) & (K Units)
Table 40. APAC Implantable Left Ventricular Assist Device Sales Market Share by Region (2021-2026)
Table 41. APAC Implantable Left Ventricular Assist Device Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 43. APAC Implantable Left Ventricular Assist Device Sales by Application (2021-2026) & (K Units)
Table 44. Europe Implantable Left Ventricular Assist Device Sales by Country (2021-2026) & (K Units)
Table 45. Europe Implantable Left Ventricular Assist Device Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 47. Europe Implantable Left Ventricular Assist Device Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Implantable Left Ventricular Assist Device Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Implantable Left Ventricular Assist Device Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Implantable Left Ventricular Assist Device Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Implantable Left Ventricular Assist Device Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Implantable Left Ventricular Assist Device
Table 53. Key Market Challenges & Risks of Implantable Left Ventricular Assist Device
Table 54. Key Industry Trends of Implantable Left Ventricular Assist Device
Table 55. Implantable Left Ventricular Assist Device Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Implantable Left Ventricular Assist Device Distributors List
Table 58. Implantable Left Ventricular Assist Device Customer List
Table 59. Global Implantable Left Ventricular Assist Device Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Implantable Left Ventricular Assist Device Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Implantable Left Ventricular Assist Device Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Implantable Left Ventricular Assist Device Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Implantable Left Ventricular Assist Device Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Implantable Left Ventricular Assist Device Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Implantable Left Ventricular Assist Device Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Implantable Left Ventricular Assist Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Implantable Left Ventricular Assist Device Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Implantable Left Ventricular Assist Device Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Implantable Left Ventricular Assist Device Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Implantable Left Ventricular Assist Device Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Implantable Left Ventricular Assist Device Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Implantable Left Ventricular Assist Device Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. J & J (AbioMed) Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 74. J & J (AbioMed) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 75. J & J (AbioMed) Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. J & J (AbioMed) Main Business
Table 77. J & J (AbioMed) Latest Developments
Table 78. Abbott (Thoratec) Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott (Thoratec) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 80. Abbott (Thoratec) Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Abbott (Thoratec) Main Business
Table 82. Abbott (Thoratec) Latest Developments
Table 83. Medtronic (HeartWare) Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 84. Medtronic (HeartWare) Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 85. Medtronic (HeartWare) Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Medtronic (HeartWare) Main Business
Table 87. Medtronic (HeartWare) Latest Developments
Table 88. Berlin Heart Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 89. Berlin Heart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 90. Berlin Heart Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Berlin Heart Main Business
Table 92. Berlin Heart Latest Developments
Table 93. Jarvik Heart Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 94. Jarvik Heart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 95. Jarvik Heart Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Jarvik Heart Main Business
Table 97. Jarvik Heart Latest Developments
Table 98. Sun Medical Technology Research Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 99. Sun Medical Technology Research Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 100. Sun Medical Technology Research Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Sun Medical Technology Research Main Business
Table 102. Sun Medical Technology Research Latest Developments
Table 103. ReliantHeart Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 104. ReliantHeart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 105. ReliantHeart Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. ReliantHeart Main Business
Table 107. ReliantHeart Latest Developments
Table 108. EVAHEART Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 109. EVAHEART Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 110. EVAHEART Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. EVAHEART Main Business
Table 112. EVAHEART Latest Developments
Table 113. BRIOHEALTH Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 114. BRIOHEALTH Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 115. BRIOHEALTH Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. BRIOHEALTH Main Business
Table 117. BRIOHEALTH Latest Developments
Table 118. Rocor Medical Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 119. Rocor Medical Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 120. Rocor Medical Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Rocor Medical Main Business
Table 122. Rocor Medical Latest Developments
Table 123. Corheart Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 124. Corheart Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 125. Corheart Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Corheart Main Business
Table 127. Corheart Latest Developments
Table 128. magAssist-Technology Basic Information, Implantable Left Ventricular Assist Device Manufacturing Base, Sales Area and Its Competitors
Table 129. magAssist-Technology Implantable Left Ventricular Assist Device Product Portfolios and Specifications
Table 130. magAssist-Technology Implantable Left Ventricular Assist Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. magAssist-Technology Main Business
Table 132. magAssist-Technology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Implantable Left Ventricular Assist Device
Figure 2. Implantable Left Ventricular Assist Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Implantable Left Ventricular Assist Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Implantable Left Ventricular Assist Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Implantable Left Ventricular Assist Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Implantable Left Ventricular Assist Device Sales Market Share by Country/Region (2025)
Figure 10. Implantable Left Ventricular Assist Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of MagLev, Full-flow Suspension
Figure 12. Product Picture of Hybrid Bearing
Figure 13. Product Picture of Other
Figure 14. Global Implantable Left Ventricular Assist Device Sales Market Share by Type in 2026
Figure 15. Global Implantable Left Ventricular Assist Device Revenue Market Share by Type (2021-2026)
Figure 16. Implantable Left Ventricular Assist Device Consumed in Hospital
Figure 17. Global Implantable Left Ventricular Assist Device Market: Hospital (2021-2026) & (K Units)
Figure 18. Implantable Left Ventricular Assist Device Consumed in Specialized Hospital
Figure 19. Global Implantable Left Ventricular Assist Device Market: Specialized Hospital (2021-2026) & (K Units)
Figure 20. Implantable Left Ventricular Assist Device Consumed in Other
Figure 21. Global Implantable Left Ventricular Assist Device Market: Other (2021-2026) & (K Units)
Figure 22. Global Implantable Left Ventricular Assist Device Sale Market Share by Application (2025)
Figure 23. Global Implantable Left Ventricular Assist Device Revenue Market Share by Application in 2026
Figure 24. Implantable Left Ventricular Assist Device Sales by Company in 2026 (K Units)
Figure 25. Global Implantable Left Ventricular Assist Device Sales Market Share by Company in 2026
Figure 26. Implantable Left Ventricular Assist Device Revenue by Company in 2026 ($ millions)
Figure 27. Global Implantable Left Ventricular Assist Device Revenue Market Share by Company in 2026
Figure 28. Global Implantable Left Ventricular Assist Device Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Implantable Left Ventricular Assist Device Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Implantable Left Ventricular Assist Device Sales 2021-2026 (K Units)
Figure 31. Americas Implantable Left Ventricular Assist Device Revenue 2021-2026 ($ millions)
Figure 32. APAC Implantable Left Ventricular Assist Device Sales 2021-2026 (K Units)
Figure 33. APAC Implantable Left Ventricular Assist Device Revenue 2021-2026 ($ millions)
Figure 34. Europe Implantable Left Ventricular Assist Device Sales 2021-2026 (K Units)
Figure 35. Europe Implantable Left Ventricular Assist Device Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Implantable Left Ventricular Assist Device Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Implantable Left Ventricular Assist Device Revenue 2021-2026 ($ millions)
Figure 38. Americas Implantable Left Ventricular Assist Device Sales Market Share by Country in 2026
Figure 39. Americas Implantable Left Ventricular Assist Device Revenue Market Share by Country (2021-2026)
Figure 40. Americas Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Figure 41. Americas Implantable Left Ventricular Assist Device Sales Market Share by Application (2021-2026)
Figure 42. United States Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Implantable Left Ventricular Assist Device Sales Market Share by Region in 2026
Figure 47. APAC Implantable Left Ventricular Assist Device Revenue Market Share by Region (2021-2026)
Figure 48. APAC Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Figure 49. APAC Implantable Left Ventricular Assist Device Sales Market Share by Application (2021-2026)
Figure 50. China Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 54. India Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Implantable Left Ventricular Assist Device Sales Market Share by Country in 2026
Figure 58. Europe Implantable Left Ventricular Assist Device Revenue Market Share by Country (2021-2026)
Figure 59. Europe Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Figure 60. Europe Implantable Left Ventricular Assist Device Sales Market Share by Application (2021-2026)
Figure 61. Germany Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 62. France Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Implantable Left Ventricular Assist Device Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Implantable Left Ventricular Assist Device Sales Market Share by Application (2021-2026)
Figure 69. Egypt Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Implantable Left Ventricular Assist Device in 2026
Figure 75. Manufacturing Process Analysis of Implantable Left Ventricular Assist Device
Figure 76. Industry Chain Structure of Implantable Left Ventricular Assist Device
Figure 77. Channels of Distribution
Figure 78. Global Implantable Left Ventricular Assist Device Sales Market Forecast by Region (2027-2032)
Figure 79. Global Implantable Left Ventricular Assist Device Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Implantable Left Ventricular Assist Device Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Implantable Left Ventricular Assist Device Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Implantable Left Ventricular Assist Device Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Implantable Left Ventricular Assist Device Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Implantable Left Ventricular Assist Device
Figure 2. Implantable Left Ventricular Assist Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Implantable Left Ventricular Assist Device Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Implantable Left Ventricular Assist Device Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Implantable Left Ventricular Assist Device Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Implantable Left Ventricular Assist Device Sales Market Share by Country/Region (2025)
Figure 10. Implantable Left Ventricular Assist Device Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of MagLev, Full-flow Suspension
Figure 12. Product Picture of Hybrid Bearing
Figure 13. Product Picture of Other
Figure 14. Global Implantable Left Ventricular Assist Device Sales Market Share by Type in 2026
Figure 15. Global Implantable Left Ventricular Assist Device Revenue Market Share by Type (2021-2026)
Figure 16. Implantable Left Ventricular Assist Device Consumed in Hospital
Figure 17. Global Implantable Left Ventricular Assist Device Market: Hospital (2021-2026) & (K Units)
Figure 18. Implantable Left Ventricular Assist Device Consumed in Specialized Hospital
Figure 19. Global Implantable Left Ventricular Assist Device Market: Specialized Hospital (2021-2026) & (K Units)
Figure 20. Implantable Left Ventricular Assist Device Consumed in Other
Figure 21. Global Implantable Left Ventricular Assist Device Market: Other (2021-2026) & (K Units)
Figure 22. Global Implantable Left Ventricular Assist Device Sale Market Share by Application (2025)
Figure 23. Global Implantable Left Ventricular Assist Device Revenue Market Share by Application in 2026
Figure 24. Implantable Left Ventricular Assist Device Sales by Company in 2026 (K Units)
Figure 25. Global Implantable Left Ventricular Assist Device Sales Market Share by Company in 2026
Figure 26. Implantable Left Ventricular Assist Device Revenue by Company in 2026 ($ millions)
Figure 27. Global Implantable Left Ventricular Assist Device Revenue Market Share by Company in 2026
Figure 28. Global Implantable Left Ventricular Assist Device Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Implantable Left Ventricular Assist Device Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Implantable Left Ventricular Assist Device Sales 2021-2026 (K Units)
Figure 31. Americas Implantable Left Ventricular Assist Device Revenue 2021-2026 ($ millions)
Figure 32. APAC Implantable Left Ventricular Assist Device Sales 2021-2026 (K Units)
Figure 33. APAC Implantable Left Ventricular Assist Device Revenue 2021-2026 ($ millions)
Figure 34. Europe Implantable Left Ventricular Assist Device Sales 2021-2026 (K Units)
Figure 35. Europe Implantable Left Ventricular Assist Device Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Implantable Left Ventricular Assist Device Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Implantable Left Ventricular Assist Device Revenue 2021-2026 ($ millions)
Figure 38. Americas Implantable Left Ventricular Assist Device Sales Market Share by Country in 2026
Figure 39. Americas Implantable Left Ventricular Assist Device Revenue Market Share by Country (2021-2026)
Figure 40. Americas Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Figure 41. Americas Implantable Left Ventricular Assist Device Sales Market Share by Application (2021-2026)
Figure 42. United States Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Implantable Left Ventricular Assist Device Sales Market Share by Region in 2026
Figure 47. APAC Implantable Left Ventricular Assist Device Revenue Market Share by Region (2021-2026)
Figure 48. APAC Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Figure 49. APAC Implantable Left Ventricular Assist Device Sales Market Share by Application (2021-2026)
Figure 50. China Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 54. India Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Implantable Left Ventricular Assist Device Sales Market Share by Country in 2026
Figure 58. Europe Implantable Left Ventricular Assist Device Revenue Market Share by Country (2021-2026)
Figure 59. Europe Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Figure 60. Europe Implantable Left Ventricular Assist Device Sales Market Share by Application (2021-2026)
Figure 61. Germany Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 62. France Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Implantable Left Ventricular Assist Device Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Implantable Left Ventricular Assist Device Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Implantable Left Ventricular Assist Device Sales Market Share by Application (2021-2026)
Figure 69. Egypt Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Implantable Left Ventricular Assist Device Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Implantable Left Ventricular Assist Device in 2026
Figure 75. Manufacturing Process Analysis of Implantable Left Ventricular Assist Device
Figure 76. Industry Chain Structure of Implantable Left Ventricular Assist Device
Figure 77. Channels of Distribution
Figure 78. Global Implantable Left Ventricular Assist Device Sales Market Forecast by Region (2027-2032)
Figure 79. Global Implantable Left Ventricular Assist Device Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Implantable Left Ventricular Assist Device Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Implantable Left Ventricular Assist Device Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Implantable Left Ventricular Assist Device Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Implantable Left Ventricular Assist Device Revenue Market Share Forecast by Application (2027-2032)
More Publications
Global Therapeutic Peptide Market Growth 2023-2029
US$ 3,660.00
February 2023
105 pages
Global Relationship Tests Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
150 pages
Global T-Cell Therapy Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
104 pages
Global Rehabilitation Parallel Bars Market Growth 2024-2030
US$ 3,660.00
September 2024
108 pages
Global Confectionery Packaging Machine Market Growth 2024-2030
US$ 3,660.00
June 2024
152 pages
